SUNPHARMA:NSE
Sun Pharmaceutical Industries Ltd
₹1.764,00
arrow_upward
+1,01%(+17,60) 1D
15 ຕ.ລ., 15 ໂມງ 30 ນາທີ 00 ວິນາທີ GMT+5:30 · INR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for SUNPHARMA...
Open
₹1.736,00
High
₹1.778,00
Low
₹1.734,10
Mkt. cap
4,23 ລ້ານລ້ານ
Avg. vol.
1,58 ລ້ານ
Volume
1,38 ລ້ານ
Dividend
0,91%
Quarterly dividend
₹4,00
Ex-dividend date
7 ກ.ລ. 2026
P/E ratio
34,97
52-wk high
₹2.046,90
52-wk low
₹1.583,70
EPS
₹50,44
Shares outstanding
0,00
No. of employees
47 ພັນ
Open
₹1.736,00
High
₹1.778,00
Low
₹1.734,10
Mkt. cap
4,23 ລ້ານລ້ານ
Avg. vol.
1,58 ລ້ານ
Volume
1,38 ລ້ານ
Dividend
0,91%
Quarterly dividend
₹4,00
Ex-dividend date
7 ກ.ລ. 2026
P/E ratio
34,97
52-wk high
₹2.046,90
52-wk low
₹1.583,70
EPS
₹50,44
Shares outstanding
0,00
No. of employees
47 ພັນ
News stories
From web sources and news partners
ad-hoc-news.de
·
10 ຊົ່ວໂມງກ່ອນ
Analyst consensus puts Sun Pharma stock at INR 2,180.00
Moneycontrol.com
·
1 ມື້ກ່ອນ
Sun Pharma: Tariff relief, innovation brighten growth outlook
ad-hoc-news.de
·
2 ມື້ກ່ອນ
Geojit raises target for Sun Pharma stock to INR 2,070.00
Profile
Sun Pharmaceutical Industries Limited is an Indian multinational pharmaceutical company headquartered in Mumbai. It manufactures and sells pharmaceutical formulations and active pharmaceutical ingredients in more than 100 countries. It is the largest pharmaceutical company in India and the fourth largest specialty generic pharmaceutical company in the world.
Around 70% of Sun Pharma’s revenue is generated from international markets. The US and India are the largest markets, accounting for over 60% of the company's turnover. Manufacturing is across 43 locations in India, the US, Asia, Africa, Australia and Europe. The products cater to therapeutic segments covering psychiatry, anti-infectives, neurology, cardiology, diabetology, gastroenterology, ophthalmology, nephrology, urology, dermatology, gynaecology, respiratory, oncology, dental and nutritionals. Its active pharmaceutical products include baricitinib, brivaracetam, and dapaglifozin. Wikipedia
About Sun Pharmaceutical Industries Ltd
CEO-
Employees47 ພັນ
Founded1983
HeadquartersGoregaon East, ມຸມໄບ, ອິນເດຍ
SectorPharmaceutical industry
Websitesunpharma.com